A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

Study Identifier
1771-201-008
CT.gov Identifier
NCT03539549
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Protocol
Available Language(s): English
Download document(s)
Statistical Analysis Plan
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Macular Degeneration - Other
    • Study Drug
  • Abicipar pegol
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    50+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Male or female participants, 50 years of age or older at the time of informed consent * Best Corrected Visual Acuity (BCVA) ≤ 78 and ≥ 24 letters (20/32 to 20/320 Snellen equivalents, respectively) at Screening and at Baseline (Day 1, prior to treatment) visits in the study eye * BCVA of 34 letters (Snellen equivalent 20/200) or better at Baseline (Day 1, prior to treatment) in the non-study eye
    Exclusion Criteria:
    * Active periocular, ocular, or intraocular infection at baseline (Day 1) (either eye) * Previous or concurrent macular laser treatment (study eye) * Cataract or refractive surgery within 3 months prior to baseline (study eye)

    Protocol Summary

    The objective of this study is to evaluate abicipar pegol for safety and treatment effects in participants with neovascular age-related macular degeneration (AMD).

    Study Locations

    Location
    Status
    Location
    Barnet Dulaney Perkins Eye Center
    Phoenix, Arizona, United States, 85016
    Status
    Not applicable
    Location
    Retina Associates Southwest, PC
    Tucson, Arizona, United States, 85710
    Status
    Not applicable
    Location
    Win Retina
    Arcadia, California, United States, 91006
    Status
    Not applicable
    Location
    Retina Consultants of Orange County
    Fullerton, California, United States, 92835
    Status
    Not applicable
    Location
    Mark B. Kislinger, MD, Inc.
    Glendora, California, United States, 91741
    Status
    Not applicable
    Location
    Atlantis Retina Institute (Atlantis Eyecare)
    Huntington Beach, California, United States, 92647
    Status
    Not applicable
    Showing {first} - {last} of {total} Results